title: Effective adjunctive use of pergolide with quetiapine for cognitive impairment and negative symptoms in schizophrenia.
authors.forename: Yoshimoto
authors.initials: Y
authors.lastname: Sekine
authors.forename: Nori
authors.initials: N
authors.lastname: Takei
authors.forename: Katsuaki
authors.initials: K
authors.lastname: Suzuki
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Nakamura
authors.forename: Kenji J
authors.initials: KJ
authors.lastname: Tsuchiya
authors.forename: Kiyokazu
authors.initials: K
authors.lastname: Takebayashi
authors.forename: Timothea
authors.initials: T
authors.lastname: Toulopoulou
authors.forename: Norio
authors.initials: N
authors.lastname: Mori
mesh_terms: D000328:Adult; D003072:Cognition Disorders / Q000188:drug therapy* / Q000523:psychology; D003987:Dibenzothiazepines / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D010479:Pergolide / Q000008:administration & dosage*; D000069348:Quetiapine Fumarate; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D003987:Dibenzothiazepines; D010479:Pergolide; D000069348:Quetiapine Fumarate